StockWatch
·
Pharmaceuticals
Board Meeting31 Oct 2026, 03:00 pm

NGL Fine Chem Board Meeting on Nov 6 to Approve Q2/H1 FY27 Results

AI Summary

NGL Fine Chem Ltd has announced a Board of Directors meeting scheduled for November 6, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the meeting will address any other matters with the Chair's permission. The company also informed that the trading window, which was closed from October 1, 2026, will remain shut until 48 hours after the declaration of these financial results, in compliance with SEBI regulations.

Key Highlights

  • Board meeting scheduled for November 6, 2026.
  • To approve unaudited standalone and consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Trading window closure extended until 48 hours post-results declaration.